Clinical trial

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

NCT01348763

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2011-10-01
PhasePHASE1
Advertisement

Conditions

HIVunresolved

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.